Concepedia

Malcolm Ellis

ME

Statistics

Publications

4

Citations

199

H-Index

4

Active since

1995

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Malcolm Ellis is an author at GlaxoSmithKline (United Kingdom) specializing in antiviral pharmacology, pharmacology, and antiviral drug design.

Publications per year

1995–2010

4

Publications

4

Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate

Martin J. Slater, Elizabeth M. Amphlett, David Andrews et al. · Journal of Medicinal Chemistry · 2007 · 90 citations

, , +16

Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease

Xianfeng Li, Yong-Kang Zhang, Yang Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 46 citations

, , +13

Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses

Denise M. Lowe, W. Alderton, Malcolm Ellis et al. · Antimicrobial Agents and Chemotherapy · 1995 · 46 citations

, , +16

Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease

Martin J. Slater, David Andrews, Graham R. Baker et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 17 citations · Full text

, , +13

1–4 of 4